How much does Luspatercept cost?

Luspatercept (Luspatercept) is a new type of drug used to treat specific types of blood diseases, mainly anemia-related diseases. It represents an important advance in medicine, providing new treatment options for patients with specific blood disorders.

Rotecept was originally developed to treat an inherited blood disorder calledbeta thalassemia. However, it was later also approved for the treatment of adult patients with anemia due to myelodysplastic syndrome (MDS) or due to low-risk MDS. This drug helps increase a patient's red blood cell count, reduce symptoms of anemia, and improve quality of life.

The working principle of Rotercept is related to erythropoietin (EPO). It simulates the effects of EPO by activating the production of red blood cells and promoting the maturation of immature red blood cells in the bone marrow, thereby increasing the production of red blood cells. This helps increase the number of red blood cells in the blood and improves symptoms of anemia.

The use of Rotercept can significantly improve symptoms of anemia, such as fatigue, shortness of breath, and feelings of weakness, thereby improving patients' quality of life. For some patients, the use of rotecept can reduce or even eliminate the need for blood transfusions, reducing transfusion-related risks. This medication helps increase a patient's red blood cell count, improves anemia, and improves strength and energy.

Rotexip is already on the market in China and has been included in medical insurance. Patients can purchase it domestically. Please consult the local hospital pharmacy for specific prices. There are only original drugs for Rotesip abroad, mainly European ones, with a price of more than 10,000 yuan.